Tag: CHRS

Coherus BioSciences faced challenges with their Q4 financial results, causing a drop in their stock value on March 13, 2024. ...

On January 23, 2024, Truist Securities analyst Robyn Karnauskas expressed her continued optimism for Coherus BioSciences (NASDAQ: CHRS) by maintaining ...

On January 22, 2024, Coherus BioSciences announced a significant development in their business strategy. They have made the decision to ...